Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases

Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases

US Patent 11981754 · Granted May 14, 2024

Estimated economic value: $88,387,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bioreducible poly (beta-amino ester)s for siRNA delivery2025
Tolerogenic artificial antigen-presenting cells2024
Biodegradable biomimetic particles2024
Multicomponent degradable cationic polymers2024
Multicomponent degradable cationic polymers2024
Nonviral gene transfer to the suprachoroidal space2024
Transcriptionally targeted and CpG-free plasmid for theranostic gene therapy2023
Methods for identifying and preparing pharmaceutical agents for activating Tie1 2023
Methods for identifying and preparing pharmaceutical agents for activating Tie1 2023
Methods for identifying and preparing pharmaceutical agents for activating Tie1 2023
Nanoparticle modification of human adipose-derived mesenchymal stem cells for tr2023
Poly(β-amino ester)-co-polyethylene glycol (PEG-PBAE-PEG) polymers for gene and 2022